| Genetics of arterial hypertension and hypotension. | |
| | |
MedLine Citation:
|
PMID: 17262198 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Human hypertension affects affects more than 20% of the adult population in industrialized countries, and it is implicated in millions of deaths worldwide each year from stroke, heart failure and ischemic heart disease. Available evidence suggests a major genetic impact on blood pressure regulation. Studies in monogenic hypertension revealed that renal salt and volume regulation systems are predominantly involved in the genesis of these disorders. Mutations here affect the synthesis of mineralocorticoids, the function of the mineralocorticoid receptor, epithelial sodium channels and their regulation by a new class of kinases, termed WNK kinases. It has been learned from monogenic hypotension that almost all ion transporters involved in the renal uptake of Na(+) have a major impact on blood pressure regulation. For essential hypertension as a complex disease, many candidate genes have been analysed. These include components of the renin-angiotensin-aldosterone system, adducin, beta-adrenoceptors, G protein subunits, regulators of G protein signalling (RGS) proteins, Rho kinases and G protein receptor kinases. At present, the individual impact of common polymorphisms in these genes on the observed blood pressure variation, on risk for stroke and as predictors of antihypertensive responses remains small and clinically irrelevant. Nevertheless, these studies have greatly augmented our knowledge on the regulation of renal functions, cellular signal transduction and the integration of both. Together, this provides the basis for the identification of novel drug targets and, hopefully, innovative antihypertensive drugs. |
| | |
Authors:
|
Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers |
Related Documents
:
|
18497458 - Population-based case-control study of renin-angiotensin system genes polymorphisms and... 9072448 - Alpha-adducin may control blood pressure both in rats and humans. 8417398 - Genetic factors that predispose the child to develop hypertension. 11427218 - Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in... 3345928 - Effects of osmoreceptor stimulation on human duodenal motor activity. 17270908 - Comparison of skin resistance between biological active points of left and right hands ... |
Publication Detail:
|
Type: Journal Article; Review Date: 2007-01-30 |
Journal Detail:
|
Title: Naunyn-Schmiedeberg's archives of pharmacology Volume: 374 ISSN: 0028-1298 ISO Abbreviation: Naunyn Schmiedebergs Arch. Pharmacol. Publication Date: 2007 Feb |
Date Detail:
|
Created Date: 2007-02-07 Completed Date: 2007-06-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0326264 Medline TA: Naunyn Schmiedebergs Arch Pharmacol Country: Germany |
Other Details:
|
Languages: eng Pagination: 429-69 Citation Subset: IM |
Affiliation:
|
Department Pharmacology, Research Center for Pharmacology and Experimental Therapeutics, Ernst-Moritz-Arndt-University Greifswald, Friedrich Loeffler Str. 23d, 17487 Greifswald, Germany. dieter.rosskopf@uni-greifswald.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aldosterone
/
metabolism Blood Pressure / genetics, physiology* Genetic Predisposition to Disease Humans Hydrocortisone / metabolism Hypertension / genetics, metabolism, physiopathology* Hypotension / genetics, metabolism, physiopathology* Models, Biological Pharmacogenetics Receptors, Mineralocorticoid / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Receptors, Mineralocorticoid; 50-23-7/Hydrocortisone; 52-39-1/Aldosterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Characterization of the gene Mre11 and evidence of silencing after polyploidization in Triticum.
Next Document: Factors affecting continence after fistulotomy for intersphincteric fistula-in-ano.